Availability of these drugs on TrumpRx is anticipated sometime in 2026
Rybelsus starts at 3 mg daily for 30 days (a dose escalation phase, not therapeutic), then increases to 7 mg
Since its launch, the center has successfully completed three evaluations by the Deutsche Forschungsgemeinschaft (DFG) - German Research Foundation
Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML
Dermatology Partners Grapevine and Keller, Recent research on GLP-1s and inflammatory skin health highlights how many of these medications also modulate immune function, reduce C-reactive protein (CRP), and downregulate inflammatory pathways
Semaglutide 2.4 mg (Wegovy) produces approximately 15-17% weight loss in similar trials